New research in the October 2023 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that intensive local-regional treatment to remove as much tumor as possible (known as “debulking”), in addition to standard systemic therapy, does not impact overall quality of life significantly for people with metastatic colorectal cancer.